Skip to main content
. 2022 Aug 3;9:956538. doi: 10.3389/fcvm.2022.956538

Table 3.

Electrophysiological parameters of anesthetized dogs (n = 10) before treatment (control) and after 1 mg/kg omipalisib treatment twice a day.

Parameter Control Omipalisib
Baseline Dofetilide Baseline Dofetilide
RR 1,000 ± 0 1,000 ± 0 1,000 ± 0 1,000 ± 0
PP 471 ± 54 615 ± 60* 506 ± 64 661 ± 118*#
QRS 123 ± 7 125 ± 7 134 ± 9* 134 ± 8*
QT 364 ± 17 490 ± 37* 432 ± 36* 607 ± 48*∧#
JT 241 ± 15 365 ± 39* 298 ± 29* 473 ± 48*∧#
LV MAPD 248 ± 21 352 ± 52* 282 ± 18 459 ± 54*∧#
RV MAPD 222 ± 25 274 ± 29* 271 ± 13* 408 ± 35*∧#
ΔMAPD 25 ± 15 75 ± 49 17 ± 12 41 ± 25
STV LV MAPD 0.70 ± 0.42 1.83 ± 0.84 0.94 ± 0.84 3.54 ± 2.84*
STV RV MAPD 0.62 ± 0.24 1.13 ± 0.64 0.83 ± 0.49 5.26 ± 4.42*∧#

Parameters in ms. Data as mean ± SD. PP interval: n = 9. Monophasic action potential duration from the left ventricle (LV MAPD, n = 9) and right ventricle (RV MAPD, n = 8) at 80% of repolarization. ΔMAPD = LV MAPD – RV MAPD. STV = short term variability. Repeated measures two-way ANOVA with Tukey's multiple comparisons test, *p < 0.05 compared to control baseline, p < 0.05 compared to control dofetilide, and #p < 0.05 compared to omipalisib baseline.